Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.

PURPOSE: The diagnosis of patients with myelodysplastic syndromes (MDS) is largely dependent on morphologic examination of bone marrow aspirates. Several criteria that form the basis of the classifications and scoring systems most commonly used in clinical practice are affected by operator-dependent...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Pellagatti, A, Benner, A, Mills, K, Cazzola, M, Giagounidis, A, Perry, J, Malcovati, L, Della Porta, MG, Jädersten, M, Verma, A, McDonald, E, Killick, S, Hellström-Lindberg, E, Bullinger, L, Wainscoat, J, Boultwood, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2013

Míreanna comhchosúla

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2011)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2009)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2008)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2007)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2008)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2010)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2007)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2014)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2005)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2008)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
de réir: Wang, L, et al.
Foilsithe / Cruthaithe: (2007)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
de réir: Wang, L, et al.
Foilsithe / Cruthaithe: (2008)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
de réir: Pellagati, A, et al.
Foilsithe / Cruthaithe: (2008)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
de réir: Jacqueline Boultwood, et al.
Foilsithe / Cruthaithe: (2008-04-01)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
de réir: Esoof, N, et al.
Foilsithe / Cruthaithe: (2006)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2017)

Gene expression profiling in the myelodysplastic syndromes.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2005)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2004)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
de réir: Jadersten, M, et al.
Foilsithe / Cruthaithe: (2005)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
de réir: Malcovati, L, et al.
Foilsithe / Cruthaithe: (2011)

Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
de réir: Pellagatti, A, et al.
Foilsithe / Cruthaithe: (2006)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
de réir: Li Wang, et al.
Foilsithe / Cruthaithe: (2008-07-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2013)

Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment
de réir: Scharenberg, C, et al.
Foilsithe / Cruthaithe: (2011)

Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts
de réir: Malcovati, L, et al.
Foilsithe / Cruthaithe: (2010)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
de réir: Jädersten, M, et al.
Foilsithe / Cruthaithe: (2009)

Clonality in the myelodysplastic syndromes.
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (2001)

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
de réir: Malcovati, L, et al.
Foilsithe / Cruthaithe: (2009)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
de réir: Fernandez-Mercado, M, et al.
Foilsithe / Cruthaithe: (2010)

Molecular pathogenesis of the myelodysplastic syndromes
de réir: Boultwood, J, et al.
Foilsithe / Cruthaithe: (1999)